Rise and Shine: What you need to know before the ASX opens
Link copied to
On Stockhead today, the 13 small caps that paid at least 10c divvies, what stocks Cyan’s experts are buying right now, and the National Stock Exchange is looking for investors in… the National Stock Exchange.
But first, here’s what you need to know about the week ahead.
Today sees the Reserve Bank of Australia release quarterly and yearly consumer price index data. An expect the onslaught of quarterly financial figures on the ASX to continue.
There are no shares coming out of escrow today, but there are seven companies due out of a trading halt either today or on Friday, after the ANZAC Day public holiday:
Gold: $US1,272.10 ($1,791.94) -0.21%
Silver: $US14.82 -1.08%
Oil (Brent): $US74.35 +0.38%
Oil (WTI): $US66.21 +0.73%
Coal: $US88.05 +1.06%
Iron ore 62pc fe: $US93.20 +0.31%
Want this headstart in your inbox every morning at 8am? Go on. Subscribe here. It’s free
A resource update from Mincor Resources (ASX:MCR) was of interest on the Stockhead Facebook chat forum, with regular poster Mel Culley saying: “Got into these a while back, just before the deal with BHP, sometimes it pays to listen in corridors to what may be going on 😂”
These were the five most-discussed stocks on trading gossip forum HotCopper at close on Tuesday:
— HotCopper (@HotCopper) April 23, 2019
It was no surprise ResApp (ASX:RAP) was amongst them: yesterday it released the latest results from its smartphone respiratory disease diagnosis app.
Shares in Tomizone (ASX: TOM) — which provides operating services for wifi software — have been jumping around lately, and this morning they spiked by 100 per cent to 0.6 cents per share.
It follows an announcement just prior to the Easter break that Tomizone got ASX approval to proceed with the acquisition of a book of equipment-rental contracts (described as the “EWL Rent Book”) for around $NZ8 million.
And the aforementioned healthcare stock ResApp (ASX:RAP) shot higher by 36 to 17c per cent after a clinical trial showed its app-based technology produced an 86 per cent success rate for diagnosing acute respiratory disease.
P2P Transport (ASX:P2P) is in strife, down 19 per cent to 30c. The company has announced, amongst other things, that both its chairman and CEO, Matthew Reynolds and Tom Varga, have resigned effective immediately.
P2P banked $16.1 million in revenue for the March quarter, down from $20.1 million in the previous quarter.
That’s all you need to know. Make the day count.